Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pleurectomy/decortication with or without hyperthermic intrathoracic cisplatin in malignant pleural mesothelioma
2013-003830-34Phase 2Active
- Sponsor
- Asklepios Fachkliniken München-Gauting
- Start
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of cisplatin in pleural mesothelioma (2 arms), sponsored by Asklepios Fachkliniken München-Gauting. Primary endpoint: overall survival. Started Sep 2013; status: active.
02
Drugs
cisplatin
03
Conditions
pleural mesothelioma
Beyond the preview
Go deeper on 2013-003830-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003830-34.